VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis
George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.
Specific probiotic strains can improve stress-related parameters in mothers after delivery.
Analyzing how different exposures affect the infant gut microbiota could help researchers identify confounding factors and potential microbiota modulators.
Understanding how antibiotics influence the microbiota’s impacts on immunotherapy may inform strategies to identify cancer patients that are more likely to respond to cancer treatment.
Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.
The authors propose a framework to leverage multi-omic datasets obtained from well-defined cohorts and to examine the impact of the GBA on ASD.
The findings of a recent study suggest that there is a causal link between the gut microbiota and infertility.
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Microbiota-based approaches could help researchers expand the therapeutic toolkit for fighting antibiotic resistance and treating tough infections.
